HomeAI · summaries
Storia in 2 fonti
Alkem rolls out single-shot semaglutide syringes at Rs 350 for diabetes, weight loss
Alkem Laboratories has launched semaglutide in single-shot pre-filled syringes in India. This makes treatment more accessible and affordable for diabetes and obesity management. The company is the first in India to offer this convenient format. This move intensifies competition in the growing Indian drug market. Alkem aims to expand access to quality medicines for better patient care.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
economictimes.indiatimes.com
Alkem rolls out single-shot semaglutide syringes at Rs 350 for diabetes, weight loss
Alkem Laboratories has launched semaglutide in single-shot pre-filled syringes in India. This makes treatment more accessible and affordable for diabetes and obesity management.…
- ·
thehindubusinessline.com
Alkem rolls out single-shot pre-filled syringes of semaglutide
Alkem launches affordable semaglutide pre-filled syringes for diabetes and obesity, expanding treatment options with multiple dose strengths.
- ·
Zydus Semaglutide approval: Delhi HC directs CDSCO to decide on patient safety concerns
The Delhi High Court has asked the Central Drugs Standard Control Organisation to review a petition challenging Zydus Lifesciences' approval for semaglutide injections. A diabetes…